Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Clinical trial NCT05836012 · COMPLETED

Trial details

NCT number: NCT05836012
Sponsor: HilleVax
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Gastroenteritis

Start date: 2023-06-10
Primary completion: 2024-01-19
Enrollment: 329

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.